These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35958562)

  • 21. A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic options.
    Liu Y; Song L; Zheng N; Shi J; Wu H; Yang X; Xue N; Chen X; Li Y; Sun C; Chen C; Tang L; Ni X; Wang Y; Shi Y; Guo J; Wang G; Zhang Z; Qin J
    Sci China Life Sci; 2022 Sep; 65(9):1866-1880. PubMed ID: 35290573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential.
    Suvarna K; Biswas D; Pai MGJ; Acharjee A; Bankar R; Palanivel V; Salkar A; Verma A; Mukherjee A; Choudhury M; Ghantasala S; Ghosh S; Singh A; Banerjee A; Badaya A; Bihani S; Loya G; Mantri K; Burli A; Roy J; Srivastava A; Agrawal S; Shrivastav O; Shastri J; Srivastava S
    Front Physiol; 2021; 12():652799. PubMed ID: 33995121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
    Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
    Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
    Costanzo M; Caterino M; Fedele R; Cevenini A; Pontillo M; Barra L; Ruoppolo M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
    Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
    Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescence.
    Gisby JS; Buang NB; Papadaki A; Clarke CL; Malik TH; Medjeral-Thomas N; Pinheiro D; Mortimer PM; Lewis S; Sandhu E; McAdoo SP; Prendecki MF; Willicombe M; Pickering MC; Botto M; Thomas DC; Peters JE
    Nat Commun; 2022 Dec; 13(1):7775. PubMed ID: 36522333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
    Wang H; Zhang Z; Zhou J; Han S; Kang Z; Chuang H; Fan H; Zhao H; Wang L; Ning Y; Sarapultsev A; Li WX; Li J; Lin Z; Luo S; Xiong N; Hu D
    Front Immunol; 2021; 12():782731. PubMed ID: 34956212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in understanding COVID-19: insights from the omics approach.
    Lin B; Liu J; Liu Y; Qin X
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):242-252. PubMed ID: 33375876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples.
    Biji A; Khatun O; Swaraj S; Narayan R; Rajmani RS; Sardar R; Satish D; Mehta S; Bindhu H; Jeevan M; Saini DK; Singh A; Gupta D; Tripathi S
    EBioMedicine; 2021 Aug; 70():103525. PubMed ID: 34392148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-organ proteomic landscape of COVID-19 autopsies.
    Nie X; Qian L; Sun R; Huang B; Dong X; Xiao Q; Zhang Q; Lu T; Yue L; Chen S; Li X; Sun Y; Li L; Xu L; Li Y; Yang M; Xue Z; Liang S; Ding X; Yuan C; Peng L; Liu W; Yi X; Lyu M; Xiao G; Xu X; Ge W; He J; Fan J; Wu J; Luo M; Chang X; Pan H; Cai X; Zhou J; Yu J; Gao H; Xie M; Wang S; Ruan G; Chen H; Su H; Mei H; Luo D; Zhao D; Xu F; Li Y; Zhu Y; Xia J; Hu Y; Guo T
    Cell; 2021 Feb; 184(3):775-791.e14. PubMed ID: 33503446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic Biomarkers to Guide Stratification for Covid-19 Treatment: Exemplifying a Path Forward Toward Implementation?
    Jankowski J
    Proteomics; 2020 Dec; 20(24):e2000229. PubMed ID: 33141520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
    Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation.
    Ciccosanti F; Antonioli M; Sacchi A; Notari S; Farina A; Beccacece A; Fusto M; Vergori A; D'Offizi G; Taglietti F; Antinori A; Nicastri E; Marchioni L; Palmieri F; Ippolito G; Piacentini M; Agrati C; Fimia GM
    Clin Proteomics; 2022 Nov; 19(1):38. PubMed ID: 36348270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
    Shen B; Yi X; Sun Y; Bi X; Du J; Zhang C; Quan S; Zhang F; Sun R; Qian L; Ge W; Liu W; Liang S; Chen H; Zhang Y; Li J; Xu J; He Z; Chen B; Wang J; Yan H; Zheng Y; Wang D; Zhu J; Kong Z; Kang Z; Liang X; Ding X; Ruan G; Xiang N; Cai X; Gao H; Li L; Li S; Xiao Q; Lu T; Zhu Y; Liu H; Chen H; Guo T
    Cell; 2020 Jul; 182(1):59-72.e15. PubMed ID: 32492406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.
    Hou X; Zhang X; Wu X; Lu M; Wang D; Xu M; Wang H; Liang T; Dai J; Duan H; Xu Y; Yu X; Li Y
    Mol Cell Proteomics; 2020 Nov; 19(11):1749-1759. PubMed ID: 32788344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics.
    Xu B; Lei Y; Ren X; Yin F; Wu W; Sun Y; Wang X; Sun Q; Yang X; Wang X; Zhang R; Li Z; Fang S; Liu J
    ACS Omega; 2021 Jul; 6(26):16826-16836. PubMed ID: 34250342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy-specific responses to COVID-19 revealed by high-throughput proteomics of human plasma.
    Gomez-Lopez N; Romero R; Escobar MF; Carvajal JA; Echavarria MP; Albornoz LL; Nasner D; Miller D; Gallo DM; Galaz J; Arenas-Hernandez M; Bhatti G; Done B; Zambrano MA; Ramos I; Fernandez PA; Posada L; Chaiworapongsa T; Jung E; Garcia-Flores V; Suksai M; Gotsch F; Bosco M; Than NG; Tarca AL
    Commun Med (Lond); 2023 Apr; 3(1):48. PubMed ID: 37016066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
    Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
    Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.